Various popular inhaled asthma medications, like Advair and Synbicort, have been in the news lately.
The problem is that when used alone, long acting beta agonists (LABAs) may be associated with asthma-related deaths, but when combined with an inhaled steroid, it appears safe and effective.
Internist Matthew Mintz summarizes the current data surrounding the issue, and makes some predictions as to how the FDA will act.
Are the safety concerns surrounding combined LABA/steroid inhalers overblown? Dr. Mintz thinks so, and hopes that the FDA would consider a modified warning on these two drugs.
Related posts:
- Clearing the confusion on asthma medications, and why Advair and Symbicort are still safe
- Why does my new asthma inhaler suck? Questions surrounding the CFC to HFA inhaler transition
- A shot of adrenaline, for asthma?
- EPO controversy
- Exubera linked to lung cancer?
- Web 2.0 and asthma management
- Cheap asthma treatment using a homemade spacer
KevinMD.com on Facebook
{ 1 comment }
I have severe asthma and two of the medicine the FDA wants to ban is on the list. I am asking that anyone that has or has known someone with a lung disorder please contact the FDA and let them know that all Americans with any disorder or disease be allowed to continue living life best they can with the current medicines available and not to ban them. Banning even one of the medicines I take can reduce my daily life by as much as 50%
http://www.fda.gov/comments.html
Comments on this entry are closed.